Gynae oncology Flashcards

1
Q

What symptoms might someone present with?

A

Post coital bleeding
Itra-menstrual bleeding
Post menopausal bleeding
Late disease: pain, DVT (pelvic thrombosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What investigations check for gynae cancers?

A
Colposcopy
Cervical biopsy
FBC, U&E, LFTs
MRI pelvis
CT abdo and chest if indicated to check for lymphatic spread
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where do gynae cancers spread too?

A

Direct/ local = vagina, bladder, parametrium, bowel

Haemotagoenous = liver and lungs (poor prognosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Where are atypical cells in CIN 1?

A

Lower 1/3rd of the epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Where are atypical cells in CIN 2?

A

Atypical cells in lower 2/3rds of epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Where are atypical cells in CIN 3?

A

Full thickness of the epithelium - only malignancy if invade through basement membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What % of women with CIN 2/3 will develop cancer within 10 years if disease untreated?

A

1/3rd (33%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How much does smoking + HPV increase the rate of cervical cancer by?

A

20 x

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Does CIN cause symptoms?

A

No - no symptoms and not visible on the cervix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

From what ages do women get 3 year smears?

A

25 - 49

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What ages do women get a smear every 5 year?

A

50 - 64 yrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What do you do if someone has mild dyskarosis and is HPV negative what would you do?

A

Refer back to normal smear programme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What histological type are most cervical cancers?

A
  • 90%

- 10% are adenocarcinomas originating from columnar epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What virus is in ALL cervical cancers?

A

HPV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the treatment options for cervical cancer 2b and above?

A

Chemo-radiotherapy alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are indications for chemo-radiotherpy for cervical cancer?

A
  • Stage 2b disease and above
  • lymph node positive MRI or after lymphadenectomy
  • Alternative to hysterectomy in lymph node negative disease
  • surgical resection margins are not clear
  • palliation for bone pain or haemmorhage (radiotherapy)
17
Q

what is the overall 5 year survival for cervical cancer?

18
Q

What is the histological type of 90% of endometrial cancers?

A

Adenocarcinoma of columnar endometrial gland cells

19
Q

What is the main aetiology to endometrial cancer?

A

Unopposed oestrogen

- higher ratio of oestrogen to progestogen

20
Q

What are common presentations of endometrial cancer?

A
  • postmenopausal bleeding (10%)
  • Premenopausal patients with irregular or intermenstraul bleed , or recent onset menorrhagia
  • Cervical smear may contain abnormal columnar cells (cervical glandular intra-epithelial neoplasia)
21
Q

What vaginal condition co-exists with endometrial cancer?

A

Atrophic vaginitis

22
Q

What investigations are done in possible endometrial cancer?

A
  • USS scan/ endometrial biopsy with pipelle or hysteroscopy (dependent on age, menopausal status and symptoms i.e. likelihood of it being cancer)
  • endometrial biopsy is required to make the diagnosis
  • MRI where spread is suspected due to symptoms or histology
  • CXR to exclude rare pulmonary spread
  • to assess patient’s fitness; FBC, U&E, glucose, ECG
23
Q

What are the treatment options for endometrial cancer?

A
  • hysterectomy or bilateral salpinoophrectomy
  • staging is surgo-pathological i.e. used for staging
  • routie lymphadenectomy is not beneficial in early stage disease and there not routine
  • Radiotherapy
24
Q

What are indications for radiotherapy in endometrial cancer?

A
  • used after hysterectomy in patients for high risk lymph node involvement
  • for pelvic reccurence (confined to pelvis) - beneficial if not previousl used
25
Describe the risk factors for lymph node involvement in endometrial cancer
- deep myometrial spread (the myometrium normally acts as a barrier) - poor tumour histology or grade - cervical stromal involvement
26
Do progestegens or chemo have a place in endometrical Ca treatment?
Yes - progestogens are rarely used but can treat distant mets - chemo may have a role in high risk early stage and advanced disease, but the response may be modest
27
What is the overall 5 year survival rates in endometrial cancer?
75%
28
what are risk factors in ovarian cancer related to?
the number of ovulations i.e. early menarche, late menopause, nulliparity
29
What is protective against ovarian cancer?
pregnancy, lactation, used of the pill (that stops ovulation)
30
What % of ovarian cancer is familial?
5% - BRCA1 = 50% lifetime risk - BRCA2 = 25% lifetime risk
31
What screening is offered for women with BRCA1/2 mutations? (for ovarian cancer)
Yearly transvaginal USS and Ca125 screening or prophlyactic salpino-oophrectomy
32
What stage of ovarian Ca do most women present with?
Stage 3-4, often absent or vague symptoms
33
What are symptoms of ovarian cancer?
- persistant abdominal distension - early satiety - loss of appetite - pelvic/ abdo pain - increased urinary urgency/ frequency
34
What would a malignant ovarian mass be like?
- rapid growth of >5cm - ascites - advanced age - bilateral massess - solid or septate nature on USS - increased vasculatiry
35
Describe the stages 1-4 of ovarian cancer?
1 - confined to ovaries 2- beyond ovaries but confined to pelvis 3 - beyond the pelvis but confined to the abdomen 4 - beyond the abdomen e.g. in the lungs or liver parenchyma